Correlation Between Lexicon Pharmaceuticals and Immunitybio

Can any of the company-specific risk be diversified away by investing in both Lexicon Pharmaceuticals and Immunitybio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lexicon Pharmaceuticals and Immunitybio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lexicon Pharmaceuticals and Immunitybio, you can compare the effects of market volatilities on Lexicon Pharmaceuticals and Immunitybio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lexicon Pharmaceuticals with a short position of Immunitybio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lexicon Pharmaceuticals and Immunitybio.

Diversification Opportunities for Lexicon Pharmaceuticals and Immunitybio

0.04

Correlation Coefficient

Lexicon Pharmaceuticals  Immunitybio

Significant diversification

The 3 months correlation between Lexicon and Immunitybio is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Lexicon Pharmaceuticals and Immunitybio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunitybio and Lexicon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lexicon Pharmaceuticals are associated (or correlated) with Immunitybio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunitybio has no effect on the direction of Lexicon Pharmaceuticals i.e., Lexicon Pharmaceuticals and Immunitybio go up and down completely randomly.

Pair Corralation between Lexicon Pharmaceuticals and Immunitybio

Given the investment horizon of 90 days Lexicon Pharmaceuticals is expected to generate 0.92 times more return on investment than Immunitybio. However, Lexicon Pharmaceuticals is 1.08 times less risky than Immunitybio. It trades about 0.0 of its potential returns per unit of risk. Immunitybio is currently generating about -0.08 per unit of risk. If you would invest  80.00  in Lexicon Pharmaceuticals on November 29, 2024 and sell it today you would lose (9.00) from holding Lexicon Pharmaceuticals or give up 11.25% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lexicon Pharmaceuticals  vs.  Immunitybio

Lexicon Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lexicon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Lexicon Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Immunitybio

Risk-Adjusted Performance

Very Weak

Over the last 90 days Immunitybio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Lexicon Pharmaceuticals and Immunitybio

The main advantage of trading using opposite Lexicon Pharmaceuticals and Immunitybio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lexicon Pharmaceuticals position performs unexpectedly, Immunitybio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunitybio will offset losses from the drop in Immunitybio's long position.

The idea behind Lexicon Pharmaceuticals and Immunitybio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.